For: | Manojlovic N, Savic G, Manojlovic S. Neoadjuvant treatment of pancreatic ductal adenocarcinoma: Whom, when and how. World J Gastrointest Surg 2024; 16(5): 1223-1230 [PMID: 38817288 DOI: 10.4240/wjgs.v16.i5.1223] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v16/i5/1223.htm |
Number | Citing Articles |
1 |
Fangqing Wang, Yang Sun, Jianwei Xu, Yufan Chen, Hui Zhang, Guotao Yin, Dexin Yu. CT-based radiomics models decode fibrosis content and molecular differences in pancreatic ductal adenocarcinoma: a multi-institutional study. Insights into Imaging 2025; 16(1) doi: 10.1186/s13244-025-02036-z
|
2 |
Osama M. Younis, Zeid K. Al-Sharif, Ahmad E. Saeed, Fares B. Qubbaj, Jehad A. Yasin, Tasnim Nour, Yassine Alami Idrissi, Anwaar Saeed. The Role of ENHO in Pancreatic Adenocarcinoma: A Bioinformatics Approach. Cancers 2025; 17(13): 2139 doi: 10.3390/cancers17132139
|
3 |
Ouyang Yonghao, Zhi Li, Yi Xiao, Lina Cai, Yannian Liao, Denghuan Lu, Hong Zhu, Rongxi Shen, Xinbo Wang. The Survival Benefits of Chemotherapy for Undifferentiated Carcinoma With Osteoclast‐Like Giant Cells of Pancreas: A Retrospective Analysis and Individual Participant Data Meta‐Analysis. Cancer Medicine 2025; 14(9) doi: 10.1002/cam4.70894
|